Mark Rosenberg, MD, MPP, President of The Task Force for Global Health, gives physicians tips on how they can play a role in reducing gun violence in their…
Rafael Yuste, MD, PhD, Professor of Neuroscience at Columbia University, discusses the many ways that the Brain Activity Map will fundamentally change medicine and neuroscience. Whether it’s pinpointing specific neural…
NEW YORK (Reuters Health) – In a randomized controlled trial, the anti-CA-125 vaccine abagovomab did not prolong survival in patients with ovarian cancer in first remission — despite…
What will it take to complete the Brain Activity Map? Rafael Yuste, MD, PhD, Professor of Neuroscience at Columbia University, talks about the latest tools being developed to measure…
NEW YORK (Reuters Health) – Even without conventional conditioning and cytoxic chemotherapy, an allogeneic hematopoietic cell transplant (HCT) can have a substantial benefit in patients with advanced hematologic…
Rafael Yuste, MD, PhD, Professor of Neuroscience at Columbia University, discusses the research goals of the brain activity map project. He explains the purpose of this ground breaking…
NEW YORK (Reuters Health) – Intraperitoneal chemotherapy may significantly improve long-term survival in ovarian cancer patients, a new study found. Data from 876 patients followed for a median…
Herbert Lepor, MD, and Danil V. Makarov, MD, MHS, continue discussing clinical options for a 58 year-old African American male with lower urinary tract symptoms in Part 2…
Herbert Lepor, MD, and Danil V. Makarov, MD, MHS, discuss the case of a 58 year-old African American male with lower urinary tract symptoms in Part 1 of…
With medical care costs continuing to rise, recent attempts to reduce emergency department use have occurred in some states and Medicaid programs. One approach is to deny or limit payment…
NEW YORK (Reuters Health) – The risk of arterial thromboembollic events related to bevacizumab treatment of colorectal cancer (CRC) in older patients is moderate in general practice, and…
